Dawnrays Pharmaceutical (Holdings) Limited (2348.HK)
HKD 1.16
(0.0%)
HKD 1.16
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.62 Billion CNY | -1.36% |
| 2022 | 3.67 Billion CNY | 9.97% |
| 2021 | 3.33 Billion CNY | 15.01% |
| 2020 | 2.9 Billion CNY | 4.21% |
| 2019 | 2.78 Billion CNY | 17.77% |
| 2018 | 2.36 Billion CNY | 8.47% |
| 2017 | 2.18 Billion CNY | 15.63% |
| 2016 | 1.88 Billion CNY | 4.58% |
| 2015 | 1.8 Billion CNY | 6.52% |
| 2014 | 1.69 Billion CNY | -1.61% |
| 2013 | 1.72 Billion CNY | 9.65% |
| 2012 | 1.56 Billion CNY | 12.61% |
| 2011 | 1.39 Billion CNY | -1.37% |
| 2010 | 1.41 Billion CNY | 25.45% |
| 2009 | 1.12 Billion CNY | 15.51% |
| 2008 | 975.21 Million CNY | 14.54% |
| 2007 | 851.39 Million CNY | 12.27% |
| 2006 | 758.33 Million CNY | 1.78% |
| 2005 | 745.05 Million CNY | 8.44% |
| 2004 | 687.08 Million CNY | 23.02% |
| 2003 | 558.49 Million CNY | 105.45% |
| 2002 | 271.83 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q2 | 3.55 Billion CNY | 0.0% |
| 2023 FY | 3.62 Billion CNY | -1.36% |
| 2023 Q4 | 3.62 Billion CNY | 0.0% |
| 2022 Q2 | 3.28 Billion CNY | 0.0% |
| 2022 Q4 | 3.67 Billion CNY | 0.0% |
| 2022 FY | 3.67 Billion CNY | 9.97% |
| 2021 Q4 | 3.33 Billion CNY | 0.0% |
| 2021 FY | 3.33 Billion CNY | 15.01% |
| 2021 Q2 | 2.86 Billion CNY | 0.0% |
| 2020 Q2 | 2.8 Billion CNY | 0.0% |
| 2020 FY | 2.9 Billion CNY | 4.21% |
| 2020 Q4 | 2.9 Billion CNY | 0.0% |
| 2019 Q4 | 2.78 Billion CNY | 0.0% |
| 2019 Q2 | 2.65 Billion CNY | 0.0% |
| 2019 FY | 2.78 Billion CNY | 17.77% |
| 2018 Q4 | 2.36 Billion CNY | 0.0% |
| 2018 Q2 | 2.43 Billion CNY | 0.0% |
| 2018 FY | 2.36 Billion CNY | 8.47% |
| 2017 FY | 2.18 Billion CNY | 15.63% |
| 2017 Q2 | 1.98 Billion CNY | 0.0% |
| 2017 Q4 | 2.18 Billion CNY | 0.0% |
| 2016 Q4 | 1.88 Billion CNY | 0.0% |
| 2016 Q2 | 1.86 Billion CNY | 0.0% |
| 2016 FY | 1.88 Billion CNY | 4.58% |
| 2015 Q4 | 1.8 Billion CNY | 0.0% |
| 2015 FY | 1.8 Billion CNY | 6.52% |
| 2015 Q2 | 1.84 Billion CNY | 0.0% |
| 2014 Q2 | 1.66 Billion CNY | 0.0% |
| 2014 FY | 1.69 Billion CNY | -1.61% |
| 2014 Q4 | 1.69 Billion CNY | 0.0% |
| 2013 Q2 | 1.66 Billion CNY | 0.0% |
| 2013 FY | 1.72 Billion CNY | 9.65% |
| 2013 Q4 | 1.72 Billion CNY | 0.0% |
| 2012 Q4 | 1.56 Billion CNY | 0.0% |
| 2012 FY | 1.56 Billion CNY | 12.61% |
| 2012 Q2 | 1.48 Billion CNY | 0.0% |
| 2011 Q2 | 1.51 Billion CNY | 0.0% |
| 2011 FY | 1.39 Billion CNY | -1.37% |
| 2011 Q4 | 1.39 Billion CNY | 0.0% |
| 2010 FY | 1.41 Billion CNY | 25.45% |
| 2010 Q2 | 1.25 Billion CNY | 0.0% |
| 2010 Q4 | 1.41 Billion CNY | 0.0% |
| 2009 FY | 1.12 Billion CNY | 15.51% |
| 2009 Q4 | 1.12 Billion CNY | 0.0% |
| 2009 Q2 | 1.05 Billion CNY | 0.0% |
| 2008 FY | 975.21 Million CNY | 14.54% |
| 2008 Q4 | 975.21 Million CNY | 0.0% |
| 2007 FY | 851.39 Million CNY | 12.27% |
| 2006 FY | 758.33 Million CNY | 1.78% |
| 2005 FY | 745.05 Million CNY | 8.44% |
| 2004 FY | 687.08 Million CNY | 23.02% |
| 2003 FY | 558.49 Million CNY | 105.45% |
| 2002 FY | 271.83 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 907.46 Million HKD | -299.206% |
| Grand Pharmaceutical Group Limited | 22.51 Billion HKD | 83.91% |
| Extrawell Pharmaceutical Holdings Limited | 1.28 Billion HKD | -181.44% |
| Wai Yuen Tong Medicine Holdings Limited | 2.09 Billion HKD | -72.91% |
| Qianhai Health Holdings Limited | 478.11 Million HKD | -657.693% |
| Lee's Pharmaceutical Holdings Limited | 2.89 Billion HKD | -25.323% |
| Essex Bio-Technology Limited | 2.82 Billion HKD | -28.12% |
| Tongfang Kontafarma Holdings Limited | 1.72 Billion HKD | -109.725% |
| PuraPharm Corporation Limited | 843.96 Million HKD | -329.244% |
| SSY Group Limited | 11.96 Billion HKD | 69.726% |
| JBM (Healthcare) Limited | 1.38 Billion HKD | -160.867% |
| Jacobson Pharma Corporation Limited | 3.48 Billion HKD | -3.895% |
| China Resources Pharmaceutical Group Limited | 271.69 Billion HKD | 98.667% |